(Q36948470)

17 August 2017

title

Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma (English)

1 reference

17 August 2017

1 reference

Laurent Greillier

1

1 reference

17 August 2017

Arnaud Cavailles

2

1 reference

17 August 2017

Anne Fraticelli

3

1 reference

17 August 2017

Arnaud Scherpereel

4

1 reference

17 August 2017

Fabrice Barlesi

5

1 reference

17 August 2017

Gianfranco Tassi

6

1 reference

17 August 2017

Pascal Thomas

7

1 reference

17 August 2017

Philippe Astoul

8

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

110

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

2248-2252

1 reference

Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Advances in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Inst

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Pleural mesothelioma: little evidence, still time to do trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Statistical validation of the EORTC prognostic model for malignant pleural mesothelioma based on three consecutive phase II trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundant.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Pleural mesothelioma: sensitivity and incidence of needle track seeding after image-guided biopsy versus surgical biopsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

The French National Mesothelioma Surveillance Program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Thoracoscopy--state of the art.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.23034

1 reference

7 January 2021

Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Malignant pleural mesothelioma: surgical roles and novel therapies.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Needle-track metastases and prophylactic radiotherapy for mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23034

7 January 2021

Identifiers

DOI

10.1002/CNCR.23034

1 reference

17 August 2017

1 reference